Actively Recruiting
Analysis of the Role of IgE Proteoforms in Health and Disease
Led by KU Leuven · Updated on 2026-01-09
200
Participants Needed
1
Research Sites
208 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this observational study is to evaluate the role of IgE proteoforms in healthy volunteers and in patients with type I allergy, patients with chronic spontaneous urticaria, patients with a recent history of anaphylaxis, patients with mastocytosis, patients with hereditary alpha tryptasemia, patients with X-linked agammaglobulinemia (XLA), and patients undergoing desensitization for venom or medication allergy.
CONDITIONS
Official Title
Analysis of the Role of IgE Proteoforms in Health and Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults with chronic spontaneous urticaria, type I allergies (including anaphylaxis and desensitization), atopic dermatitis, mastocytosis, X-linked agammaglobulinemia, or hereditary alpha tryptasemia
- Healthy adults matched by age and gender to allergic patients
- Ability to give informed consent
- Clinical information available about allergy symptoms, severity, medication use, medical history, and laboratory testing
You will not qualify if you...
- No informed consent given
- Younger than 18 years old
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UZ/KU Leuven
Leuven, Vlaams-Brabant, Belgium, 3000
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
9
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here